Table 2 The reasons for drug discontinuation
Reason for drug discontinuation, n (%) | Mirogabalin group (N = 13) | Pregabalin group (N = 21) |
|---|---|---|
2 weeks after initiation | 0 (0) | 7 (33.3) |
  Ineffective | 0 (0) | 2 (9.5) |
  Adverse events | 0 (0) | 5 (23.8) |
4 weeks after initiation | 2 (15.4) | 4 (19.0) |
  CIPN sufficiently improved | 1 (7.7) | 1 (4.8) |
  Adverse events | 1 (7.7) | 0 (0) |
  Ineffective | 0 (0) | 3 (14.3) |